BMPR-1A

BMPR-1A 분자 정보

영어 이름Bone morphogenetic protein receptor type-1A시판 약물 수2
임상 약물 수2표적 별명Bone Morphogenetic Protein Receptor Type 1A,EC 2.7.11,Activin receptor-like kinase 3,Bone morphogenetic protein receptor type-1A,ALK3,BMPR1A,Bone Morphogenetic Protein Receptor, Type IA,Serine/Threonine-Protein Kinase Receptor R5,ACVRLK3,BMPR-1A,SKR5,Activin A Receptor, Type II-Like Kinase 3,CD292 Antigen,EC 2.7.11.30,10q23del,CD292,BMP type-1A receptor,ALK-3,EC:2.7.11.30
최고 연구 개발 단계Approved
영어 이름Bone morphogenetic protein receptor type-1A
표적 별명Bone Morphogenetic Protein Receptor Type 1A,EC 2.7.11,Activin receptor-like kinase 3,Bone morphogenetic protein receptor type-1A,ALK3,BMPR1A,Bone Morphogenetic Protein Receptor, Type IA,Serine/Threonine-Protein Kinase Receptor R5,ACVRLK3,BMPR-1A,SKR5,Activin A Receptor, Type II-Like Kinase 3,CD292 Antigen,EC 2.7.11.30,10q23del,CD292,BMP type-1A receptor,ALK-3,EC:2.7.11.30
시판 약물 수2
임상 약물 수2
최고 연구 개발 단계Approved

BMPR-1A 제품 목록

  • 속성

    Protein (2)

  • 제품 라이브러리

    온라인 (2)

  • Human (2)

  • 태그

    Fc Tag (1)His Tag (1)

  • 마커

    Unconjugated (2)

제품 번호발현 시스템제품 설명단백질 구조순도특성
AL3-H5259
Human
HEK293
Human BMPR-1A / ALK-3 Protein, Fc Tag
AL3-H52H9
Human
HEK293
Human BMPR-1A / ALK-3 Protein, His Tag (MALS verified)
총 수량2
  • 1

BMPR-1A분자 배경

The bone morphogenetic protein receptor, type IA is also known as BMPR1A or ALK3 is a protein which in humans is encoded by the BMPR1A gene. BMPR1A has also been designated as CD292 (cluster of differentiation 290). The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A (this protein) and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. Alk3-mediated BMP signaling in AV endocardial/mesenchymal cells plays a central role during cushion morphogenesis.

BMPR-1A분자 별명

BMPR-1A,ALK-3,ACVRLK3,CD292,SKR5

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Recombinant Human Bone Morphogenetic Protein-2(University Of Baghdad)Phase 1 ClinicalUniversity Of BaghdadDiabetes Mellitus; Hematologic Diseases; Hypertension
상세
Recombinant human bone morphogenetic protein 4 (Stemgen)HS-214; hrBMP4Phase 1 ClinicalStemgenAsthma; Bronchiolitis Obliterans; Glioblastoma; Lung Diseases; Rejection of lung transplantation
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Dibotermin alfaYM-484; rhBMP-2/CPMApprovedMedtronicInductosEUTibial FracturesMedtronic Biopharma Bv2002-09-09Fractures, Bone; Osteoarthritis; Osteoarthritis, Spine; Radius Fractures; Tibial Fractures; Tooth Injuries
상세
DWP-431DWP-431; rhBMP-2ApprovedDaewoong Pharmaceutical Co LtdNovosis, Novosis-DentalSouth KoreaAlveolar Bone LossDaewoong Pharmaceutical Co Ltd2013-01-01Alveolar Bone Loss; Intervertebral Disc Degeneration
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호